ZNF469
Zinc finger protein 469
Also known as: KIAA1858, Zfp469, ZN469_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96JG9
- Gene
- ZNF469
- Ensembl
- ENSG00000225614
- Chromosome
- 16
- Canonical length
- 3953 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cell Junctions
OverviewNCBI Gene
This gene encodes a zinc-finger protein. Low-percent homology to certain collagens suggests that it may function as a transcription factor or extra-nuclear regulator factor for the synthesis or organization of collagen fibers. Mutations in this gene cause brittle cornea syndrome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
3953 residues, UniProt reviewed canonical sequence.
>Q96JG9|ZNF469
1 MPGERPRGAP PPTMTGDLQP RQVASSPGHP SQPPLEDNTP ATRTTKGARE AGGQAQAMEL
61 PEAQPRQARD GELKPPSLRG QAPSSTPGKR GSPQTPPGRS PLQAPSRLAG RAEGSPPQRY
121 ILGIASSRTK PTLDETPENP QLEAAQLPEV DTPQGPGTGA PLRPGLPRTE AQPAAEELGF
181 HRCFQEPPSS FTSTNYTSPS ATPRPPAPGP PQSRGTSPLQ PGSYPEYQAS GADSWPPAAE
241 NSFPGANFGV PPAEPEPIPK GSRPGGSPRG VSFQFPFPAL HGASTKPFPA DVAGHAFTNG
301 PLVFAFHQPQ GAWPEEAVGT GPAYPLPTQP APSPLPCYQG QPGGLNRHSD LSGALSSPGA
361 AHSAPRPFSD SLHKSLTKIL PERPPSAQDG LGSTRGPPSS LPQRHFPGQA YRASGVDTSP
421 GPPDTELAAP GPPPARLPQL WDPTAAPYPT PPGGPLAATR SMFFNGQPSP GQRLCLPQSA
481 PLPWPQVLPT ARPSPHGMEM LSRLPFPAGG PEWQGGSQGA LGTAGKTPGP REKLPAVRSS
541 QGGSPALFTY NGMTDPGAQP LFFGVAQPQV SPHGTPSLPP PRVVGASPSE SPLPSPATNT
601 AGSTCSSLSP MSSSPANPSS EESQLPGPLG PSAFFHPPTH PQETGSPFPS PEPPHSLPTH
661 YQPEPAKAFP FPADGLGAEG AFQCLEETPF PHEGPEVGRG GLQGFPRAPP PYPTHHFSLS
721 SASLDQLDVL LTCRQCDRNY SSLAAFLAHR QFCGLLLARA KDGHQRSPGP PGLPSPPAAP
781 RVPADAHAGL LSHAKTFLLA GDAQAEGKDD PLRTGFLPSL AATPFPLPAS DLDMEDDAKL
841 DSLITEALNG MEYQSDNPEI DSSFIDVFAD EEPSGPRGPS SGHPLKSKAG VTPESKAPPP
901 LPAATPDPQT PRPGDRGCPA RGRPKTRSLG LAPTEADAPS QGRQQRRGKQ LKLFRKDLDS
961 GGAAEGSGSG GGGRASGLRP RRNDGLGERP PPRPRRPRTQ APGSRADPAP RVPRAAALPE
1021 ETRSSRRRRL PPRKDPRKRK ARGGAWGKEL ILKIVQQKNR RHRRLGRRAG RCGSLAAGRP
1081 RPGAEDRRLR EYDFASESEE DEQPPPRGPG FRGRRGRGEK RKEVELTQGP REDEPQKPRK
1141 AARQEAGGDG APANPEEPGG SRPGPGRSPQ ARGPSRSLET GAAAREGGPK CADRPSVAPK
1201 DPLQVPTNTE TSEETRPSLD FPQEAKEPET AEESAPDSTE FTEALRSPPA ACAGEMGASP
1261 GLLIPEQPPP SRHDTGTPKP SGSLANTAPH GSSPTPGVGS LLGGPGGTQA PVSHNSKDPP
1321 ARQPGEFLAP VANPSSTACP KPSVLSSKIS SFGCDPAGFN RDPLGVPVAK KGPQPYSSPH
1381 SELFLGPKDL AGCFLEELHP KPSARDAPPA SSSCLCQDGE DAGSLEPQLP RSPPGTAETE
1441 PGRAASPPTL ESSSLFPDLP VDRFDPPLYG SLSANRDSGL PFACADPPQK TVPSDPPYPS
1501 FLLLEEVSPM LPSHFPDLSG GKVLSKTCPP ERTVVPGAAP SLPGKGSGCS VALMSHLSED
1561 ELEIQKLVTE LESQLQRSKD TRGAPRELAE AESVGRVELG TGTEPPSQRR TCQATVPHED
1621 TFSAADLTRV GESTAHREGA ESAVATVEAV QGRPGGTWPC PASFHPGHAA LLPCAQEDLV
1681 SGAPFSPRGA NFHFQPVQKA GASKTGLCQA EGDSRPPQDV CLPEPSKQPG PQLDAGSLAK
1741 CSPDQELSFP KNKEAASSQE SEDSLRLLPC EQRGGFLPEP GTADQPHRGA PAPEAFGSPA
1801 VHLAPDLAFQ GDGAPPLDAT WPFGASPSHA AQGHSAGRAG GHLHPTAGRP GFEGNEFAPA
1861 GASSLTAPRG REAWLVPVPS PACVSNTHPS RRSQDPALSP PIRQLQLPGP GVAKSKDGIL
1921 GLQELTPAAQ SPPRVNPSGL EGGTVEGGKV ACGPAQGSPG GVQVTTLPAV AGHQLGLEAD
1981 GHWGLLGQAE KTQGQGTANQ LQPENGVSPG GTDNHASVNA SPKTALTGPT EGAVLLEKCK
2041 GSRAAMSLQE EAEPTPSPPS PNRESLALAL TAAHSRSGSE GRTPERASSP GLNKPLLATG
2101 DSPAPSVGDL AACAPSPTSA AHMPCSLGPL PREDPLTSPS RAQGGLGGQL PASPSCRDPP
2161 GPQQLLACSP AWAPLEEADG VQATTDTGAE DSPVAPPSLT TSPCDPKEAL AGCLLQGEGS
2221 PLEDPSSWPP GSVSAVTCTH SGDTPKDSTL RIPEDSRKEK LWESPGRATS PPLAGAVSPS
2281 VAVRATGLSS TPTGDEAQAG RGLPGPDPQS RGAPPHTNPD RMPRGHSSYS PSNTARLGHR
2341 EGQAVTAVPT EPPTLQGAGP DSPACLEGEM GTSSKEPEDP GTPETGRSGA TKMPRVTCPS
2401 TGLGLGRTTA PSSTASDFQS DSPQSHRNAS HQTPQGDPLG PQDLKQRSRG YKKKPASTEN
2461 GQWKGQAPHG PVTCEVCAAS FRSGPGLSRH KARKHRPHPG APAEPSPAAL PAQQPLEPLA
2521 QKCQPPRKKS HRVSGKERPN HSRGDPSHVT QPPPAQGSKE VLRAPGSPHS QQLHPPSPTE
2581 HEVDVKTPAS KPRPDQARED ELHPKQAEKR EGRRWRREPT VDSPSHSEGK SNKKRGKLRG
2641 RRLREESILP VSADVISDGR GSRPSPAMAS YAASPSHCLS VEGGPEADGE QPPRLATLGP
2701 GVMEGAAETD QEALCAGETG AQKPPGDRML CPGRMDGAAL GEQPTGQKGA SARGFWGPRE
2761 TKALGVCKES GSEPAEDSSR AHSRSEEGVW EENTPPLGPL GFPETSSSPA DSTTSSCLQG
2821 LPDNPDTQGG VQGPEGPTPD ASGSSAKDPP SLFDDEVSFS QLFPPGGRLT RKRNPHVYGK
2881 RCEKPVLPLP TQPSFEEGGD PTLGPARLPT DLSDSSSLCL CHEDPWEDED PAGLPESFLL
2941 DGFLNSRVPG IDPWAPGLSL WALEPSREAG AEKLPSHCPE DDRPEAIPEL HMVPAAWRGL
3001 EMPAPADDSS SSLGDVSPEP PSLERERCDG GLPGNTHLLP LRATDFEVLS TKFEMQDLCF
3061 LGPFEDPVGL PGPSFLDFEG TASSQGPQSR RTEEAAGAGR AQGRGRPAKG RRASYKCKVC
3121 FQRFRSLGEL DLHKLAHTPA PPPTCYMCVE RRFGSRELLR GHLQERHAQS KAGPWACGMC
3181 LKEVADVWMY NEHLREHAVR FARRGQARRS LGDLPGGLEG SSAVAHLLNS ITEPAPKHHR
3241 GKRSAGKAAG SPGDPWGQEG EAKKDSPGER AKPRARSTPS NPDGAATPDS ASATALADAG
3301 SPGPPRTTPS PSPDPWAGGE PLLQATPVHE ACKDPSRDCH HCGKRFPKPF KLQRHLAVHS
3361 PQRVYLCPRC PRVYPEHGEL LAHLGGAHGL LERPELQHTP LYACELCATV MRIIKKSFAC
3421 SSCNYTFAKK EQFDRHMNKH LRGGRQPFAF RGVRRPGAPG QKARALEGTL PSKRRRVAMP
3481 GSAPGPGEDR PPPRGSSPIL SEGSLPALLH LCSEVAPSTT KGWPETLERP VDPVTHPIRG
3541 CELPSNHQEC PPPSLSPFPA ALADGRGDCA LDGALERPEN EASPGSPGPL LQQALPLGAS
3601 LPRPGARGQD AEGKRAPLVF SGKRRAPGAR GRCAPDHFQE DHLLQKEKEV SSSHMVSEGG
3661 PRGAFHKGSA TKPAGCQSSS KDRSAASTPS KALKFPVHPR KAVGSLAPGE LARGTENGMK
3721 PATPKAKPGP SSQGSGSPRP GTKTGGGSQP QPASGQLQSE TATTPAKPSF PSRSPAPERL
3781 PARAQAKSCT KGPREAGEQG PHGSLGPKEK GESSTKRKKG QVPGPARSES VGSFGRAPSA
3841 PDKPPRTPRK QATPSRVLPT KPKPNSQNKP RPPPSEQRKA EPGHTQRKDR LGKAFPQGRP
3901 LLRPPKRGTA VHGAEPAEPH THRTAEAQSD LLSQLFGQRL TGFKIPLKKD ASELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF469 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 2.1 nTPM
Expression across tissuesHPA
Tissue
- ovary: 2.1 nTPM
- hippocampal formation: 1.4 nTPM
- amygdala: 1.3 nTPM
- cerebral cortex: 1.3 nTPM
- cervix: 1.3 nTPM
- endometrium: 1.3 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 27 nCPM
- oligodendrocytes: 20 nCPM
- microglia: 8.9 nCPM
- cdc: 8.5 nCPM
- macrophages: 8.2 nCPM
- hofbauer cells: 7.3 nCPM
Immune cell
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- hippocampal formation: 13 nTPM
- amygdala: 12 nTPM
- medulla oblongata: 10 nTPM
- cerebral cortex: 9.5 nTPM
- midbrain: 9.1 nTPM
- pons: 8.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ZNF469.
Disease | AllUniProt
Conditions ZNF469 is implicated in, by any mechanism.
- Brittle cornea syndrome 1 (BCS1) MIM:229200
Disease | GeneticClinVar
201 pathogenic / likely-pathogenic of 5,293 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Brittle cornea syndrome 1
- Cardiovascular phenotype
- Fanconi anemia complementation group A
- Keratoconus 1
- Ehlers-Danlos syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.72
- gnomAD missense Z
- 0.77
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- regulation of extracellular matrix organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger C2H2-type
- Zinc finger C2H2 superfamily
- Zinc finger, C2H2 type
- Zinc finger protein 469
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF469 as an antibody target. Whether an autoantibody or antibody against ZNF469 could matter depends on whether native ZNF469 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF469 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF469 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...